nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—Prednisone—ankylosing spondylitis	0.119	0.164	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—ankylosing spondylitis	0.0769	0.106	CbGbCtD
Fosphenytoin—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0755	0.104	CbGbCtD
Fosphenytoin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0613	0.0848	CbGbCtD
Fosphenytoin—ALB—Methotrexate—ankylosing spondylitis	0.0595	0.0823	CbGbCtD
Fosphenytoin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0572	0.0791	CbGbCtD
Fosphenytoin—CYP2C19—Dexamethasone—ankylosing spondylitis	0.048	0.0664	CbGbCtD
Fosphenytoin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0465	0.0643	CbGbCtD
Fosphenytoin—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0399	0.0552	CbGbCtD
Fosphenytoin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0399	0.0552	CbGbCtD
Fosphenytoin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0393	0.0544	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—ankylosing spondylitis	0.0372	0.0514	CbGbCtD
Fosphenytoin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0232	0.0321	CbGbCtD
Fosphenytoin—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000559	0.00202	CcSEcCtD
Fosphenytoin—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.000559	0.00202	CcSEcCtD
Fosphenytoin—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.000543	0.00196	CcSEcCtD
Fosphenytoin—Bradycardia—Betamethasone—ankylosing spondylitis	0.000526	0.0019	CcSEcCtD
Fosphenytoin—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000526	0.0019	CcSEcCtD
Fosphenytoin—Mood swings—Methotrexate—ankylosing spondylitis	0.000515	0.00186	CcSEcCtD
Fosphenytoin—Ataxia—Methotrexate—ankylosing spondylitis	0.000511	0.00184	CcSEcCtD
Fosphenytoin—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000507	0.00183	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000502	0.00181	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.0005	0.0018	CcSEcCtD
Fosphenytoin—Malaise—Prednisolone—ankylosing spondylitis	0.000486	0.00175	CcSEcCtD
Fosphenytoin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.000485	0.00175	CcSEcCtD
Fosphenytoin—Vertigo—Prednisolone—ankylosing spondylitis	0.000484	0.00175	CcSEcCtD
Fosphenytoin—Syncope—Prednisolone—ankylosing spondylitis	0.000483	0.00174	CcSEcCtD
Fosphenytoin—Back pain—Triamcinolone—ankylosing spondylitis	0.000479	0.00173	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000474	0.00171	CcSEcCtD
Fosphenytoin—Asthma—Methotrexate—ankylosing spondylitis	0.00047	0.0017	CcSEcCtD
Fosphenytoin—Convulsion—Prednisolone—ankylosing spondylitis	0.000467	0.00169	CcSEcCtD
Fosphenytoin—Hypertension—Prednisolone—ankylosing spondylitis	0.000465	0.00168	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00046	0.00166	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000459	0.00166	CcSEcCtD
Fosphenytoin—Bradycardia—Prednisone—ankylosing spondylitis	0.000458	0.00165	CcSEcCtD
Fosphenytoin—Discomfort—Prednisolone—ankylosing spondylitis	0.000453	0.00164	CcSEcCtD
Fosphenytoin—Malaise—Triamcinolone—ankylosing spondylitis	0.000447	0.00161	CcSEcCtD
Fosphenytoin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000446	0.00161	CcSEcCtD
Fosphenytoin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000445	0.00161	CcSEcCtD
Fosphenytoin—Syncope—Triamcinolone—ankylosing spondylitis	0.000444	0.0016	CcSEcCtD
Fosphenytoin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000444	0.0016	CcSEcCtD
Fosphenytoin—Syncope—Methylprednisolone—ankylosing spondylitis	0.000443	0.0016	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00044	0.00159	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—ankylosing spondylitis	0.000439	0.00159	CcSEcCtD
Fosphenytoin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000436	0.00157	CcSEcCtD
Fosphenytoin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000435	0.00157	CcSEcCtD
Fosphenytoin—Shock—Prednisolone—ankylosing spondylitis	0.000433	0.00156	CcSEcCtD
Fosphenytoin—Cough—Triamcinolone—ankylosing spondylitis	0.000432	0.00156	CcSEcCtD
Fosphenytoin—Convulsion—Triamcinolone—ankylosing spondylitis	0.000429	0.00155	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisolone—ankylosing spondylitis	0.000429	0.00155	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000429	0.00155	CcSEcCtD
Fosphenytoin—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000428	0.00155	CcSEcCtD
Fosphenytoin—Hypertension—Triamcinolone—ankylosing spondylitis	0.000428	0.00154	CcSEcCtD
Fosphenytoin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000427	0.00154	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000425	0.00153	CcSEcCtD
Fosphenytoin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000422	0.00152	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—ankylosing spondylitis	0.000421	0.00152	CcSEcCtD
Fosphenytoin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000421	0.00152	CcSEcCtD
Fosphenytoin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000421	0.00152	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000417	0.00151	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000417	0.00151	CcSEcCtD
Fosphenytoin—Discomfort—Triamcinolone—ankylosing spondylitis	0.000417	0.0015	CcSEcCtD
Fosphenytoin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000416	0.0015	CcSEcCtD
Fosphenytoin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000413	0.00149	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—ankylosing spondylitis	0.000412	0.00149	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000407	0.00147	CcSEcCtD
Fosphenytoin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000407	0.00147	CcSEcCtD
Fosphenytoin—Malaise—Dexamethasone—ankylosing spondylitis	0.000405	0.00146	CcSEcCtD
Fosphenytoin—Malaise—Betamethasone—ankylosing spondylitis	0.000405	0.00146	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000404	0.00146	CcSEcCtD
Fosphenytoin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000404	0.00146	CcSEcCtD
Fosphenytoin—Vertigo—Betamethasone—ankylosing spondylitis	0.000404	0.00146	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000404	0.00146	CcSEcCtD
Fosphenytoin—Syncope—Betamethasone—ankylosing spondylitis	0.000403	0.00146	CcSEcCtD
Fosphenytoin—Syncope—Dexamethasone—ankylosing spondylitis	0.000403	0.00146	CcSEcCtD
Fosphenytoin—Infection—Triamcinolone—ankylosing spondylitis	0.000402	0.00145	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—ankylosing spondylitis	0.000401	0.00145	CcSEcCtD
Fosphenytoin—Infection—Methylprednisolone—ankylosing spondylitis	0.000401	0.00145	CcSEcCtD
Fosphenytoin—Shock—Triamcinolone—ankylosing spondylitis	0.000398	0.00144	CcSEcCtD
Fosphenytoin—Insomnia—Prednisolone—ankylosing spondylitis	0.000398	0.00144	CcSEcCtD
Fosphenytoin—Shock—Methylprednisolone—ankylosing spondylitis	0.000397	0.00143	CcSEcCtD
Fosphenytoin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000395	0.00143	CcSEcCtD
Fosphenytoin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000395	0.00143	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—ankylosing spondylitis	0.000395	0.00143	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000395	0.00143	CcSEcCtD
Fosphenytoin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000395	0.00142	CcSEcCtD
Fosphenytoin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000394	0.00142	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000391	0.00141	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00039	0.00141	CcSEcCtD
Fosphenytoin—Convulsion—Betamethasone—ankylosing spondylitis	0.00039	0.00141	CcSEcCtD
Fosphenytoin—Convulsion—Dexamethasone—ankylosing spondylitis	0.00039	0.00141	CcSEcCtD
Fosphenytoin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000388	0.0014	CcSEcCtD
Fosphenytoin—Hypertension—Betamethasone—ankylosing spondylitis	0.000388	0.0014	CcSEcCtD
Fosphenytoin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000383	0.00138	CcSEcCtD
Fosphenytoin—Myalgia—Betamethasone—ankylosing spondylitis	0.000383	0.00138	CcSEcCtD
Fosphenytoin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000378	0.00137	CcSEcCtD
Fosphenytoin—Discomfort—Betamethasone—ankylosing spondylitis	0.000378	0.00137	CcSEcCtD
Fosphenytoin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000377	0.00136	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000373	0.00135	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000368	0.00133	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000368	0.00133	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000367	0.00132	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000367	0.00132	CcSEcCtD
Fosphenytoin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000366	0.00132	CcSEcCtD
Fosphenytoin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000365	0.00132	CcSEcCtD
Fosphenytoin—Infection—Dexamethasone—ankylosing spondylitis	0.000365	0.00132	CcSEcCtD
Fosphenytoin—Infection—Betamethasone—ankylosing spondylitis	0.000365	0.00132	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000363	0.00131	CcSEcCtD
Fosphenytoin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000363	0.00131	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000362	0.00131	CcSEcCtD
Fosphenytoin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000362	0.00131	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—ankylosing spondylitis	0.000362	0.00131	CcSEcCtD
Fosphenytoin—Shock—Betamethasone—ankylosing spondylitis	0.000361	0.0013	CcSEcCtD
Fosphenytoin—Shock—Dexamethasone—ankylosing spondylitis	0.000361	0.0013	CcSEcCtD
Fosphenytoin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000361	0.0013	CcSEcCtD
Fosphenytoin—Agitation—Prednisone—ankylosing spondylitis	0.00036	0.0013	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000359	0.0013	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000359	0.0013	CcSEcCtD
Fosphenytoin—Tachycardia—Betamethasone—ankylosing spondylitis	0.000358	0.00129	CcSEcCtD
Fosphenytoin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000358	0.00129	CcSEcCtD
Fosphenytoin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000356	0.00128	CcSEcCtD
Fosphenytoin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000355	0.00128	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000355	0.00128	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000355	0.00128	CcSEcCtD
Fosphenytoin—Malaise—Prednisone—ankylosing spondylitis	0.000353	0.00127	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—ankylosing spondylitis	0.000352	0.00127	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—ankylosing spondylitis	0.000351	0.00127	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—ankylosing spondylitis	0.000351	0.00127	CcSEcCtD
Fosphenytoin—Anorexia—Betamethasone—ankylosing spondylitis	0.00035	0.00126	CcSEcCtD
Fosphenytoin—Anorexia—Dexamethasone—ankylosing spondylitis	0.00035	0.00126	CcSEcCtD
Fosphenytoin—Urticaria—Prednisolone—ankylosing spondylitis	0.000349	0.00126	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000344	0.00124	CcSEcCtD
Fosphenytoin—Hypotension—Betamethasone—ankylosing spondylitis	0.000343	0.00124	CcSEcCtD
Fosphenytoin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000343	0.00124	CcSEcCtD
Fosphenytoin—Convulsion—Prednisone—ankylosing spondylitis	0.000339	0.00122	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—ankylosing spondylitis	0.000338	0.00122	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—ankylosing spondylitis	0.000337	0.00122	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000334	0.00121	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000334	0.00121	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—ankylosing spondylitis	0.000333	0.0012	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—ankylosing spondylitis	0.000333	0.0012	CcSEcCtD
Fosphenytoin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000333	0.0012	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000333	0.0012	CcSEcCtD
Fosphenytoin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000332	0.0012	CcSEcCtD
Fosphenytoin—Insomnia—Betamethasone—ankylosing spondylitis	0.000332	0.0012	CcSEcCtD
Fosphenytoin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00033	0.00119	CcSEcCtD
Fosphenytoin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00033	0.00119	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—ankylosing spondylitis	0.000329	0.00119	CcSEcCtD
Fosphenytoin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000323	0.00117	CcSEcCtD
Fosphenytoin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000323	0.00117	CcSEcCtD
Fosphenytoin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000321	0.00116	CcSEcCtD
Fosphenytoin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000321	0.00116	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00032	0.00116	CcSEcCtD
Fosphenytoin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00032	0.00115	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00032	0.00115	CcSEcCtD
Fosphenytoin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000319	0.00115	CcSEcCtD
Fosphenytoin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000319	0.00115	CcSEcCtD
Fosphenytoin—Infection—Prednisone—ankylosing spondylitis	0.000318	0.00115	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—ankylosing spondylitis	0.000317	0.00114	CcSEcCtD
Fosphenytoin—Shock—Prednisone—ankylosing spondylitis	0.000314	0.00113	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisone—ankylosing spondylitis	0.000312	0.00113	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000309	0.00112	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—ankylosing spondylitis	0.000305	0.0011	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000304	0.0011	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—ankylosing spondylitis	0.000302	0.00109	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000302	0.00109	CcSEcCtD
Fosphenytoin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000302	0.00109	CcSEcCtD
Fosphenytoin—Malaise—Methotrexate—ankylosing spondylitis	0.000295	0.00107	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—ankylosing spondylitis	0.000294	0.00106	CcSEcCtD
Fosphenytoin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000293	0.00106	CcSEcCtD
Fosphenytoin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000292	0.00105	CcSEcCtD
Fosphenytoin—Urticaria—Betamethasone—ankylosing spondylitis	0.000292	0.00105	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000291	0.00105	CcSEcCtD
Fosphenytoin—Dizziness—Prednisolone—ankylosing spondylitis	0.000291	0.00105	CcSEcCtD
Fosphenytoin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00029	0.00105	CcSEcCtD
Fosphenytoin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00029	0.00105	CcSEcCtD
Fosphenytoin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00029	0.00105	CcSEcCtD
Fosphenytoin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00029	0.00105	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—ankylosing spondylitis	0.000289	0.00104	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000287	0.00104	CcSEcCtD
Fosphenytoin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000286	0.00103	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—ankylosing spondylitis	0.000286	0.00103	CcSEcCtD
Fosphenytoin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000286	0.00103	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—ankylosing spondylitis	0.000284	0.00102	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000281	0.00102	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—ankylosing spondylitis	0.000279	0.00101	CcSEcCtD
Fosphenytoin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000279	0.00101	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000278	0.001	CcSEcCtD
Fosphenytoin—Rash—Prednisolone—ankylosing spondylitis	0.000277	0.001	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000277	0.001	CcSEcCtD
Fosphenytoin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000276	0.000997	CcSEcCtD
Fosphenytoin—Headache—Prednisolone—ankylosing spondylitis	0.000276	0.000994	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—ankylosing spondylitis	0.000275	0.000994	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—ankylosing spondylitis	0.000273	0.000986	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—ankylosing spondylitis	0.000269	0.000972	CcSEcCtD
Fosphenytoin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000267	0.000965	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000267	0.000964	CcSEcCtD
Fosphenytoin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000267	0.000963	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—ankylosing spondylitis	0.000265	0.000958	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000263	0.000951	CcSEcCtD
Fosphenytoin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000263	0.00095	CcSEcCtD
Fosphenytoin—Asthenia—Betamethasone—ankylosing spondylitis	0.000263	0.00095	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000262	0.000944	CcSEcCtD
Fosphenytoin—Nausea—Prednisolone—ankylosing spondylitis	0.000261	0.000943	CcSEcCtD
Fosphenytoin—Pruritus—Betamethasone—ankylosing spondylitis	0.00026	0.000937	CcSEcCtD
Fosphenytoin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00026	0.000937	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000258	0.000932	CcSEcCtD
Fosphenytoin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000257	0.000928	CcSEcCtD
Fosphenytoin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000257	0.000926	CcSEcCtD
Fosphenytoin—Rash—Triamcinolone—ankylosing spondylitis	0.000255	0.00092	CcSEcCtD
Fosphenytoin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000255	0.00092	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—ankylosing spondylitis	0.000255	0.000919	CcSEcCtD
Fosphenytoin—Rash—Methylprednisolone—ankylosing spondylitis	0.000254	0.000918	CcSEcCtD
Fosphenytoin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000254	0.000917	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—ankylosing spondylitis	0.000254	0.000916	CcSEcCtD
Fosphenytoin—Headache—Triamcinolone—ankylosing spondylitis	0.000253	0.000914	CcSEcCtD
Fosphenytoin—Headache—Methylprednisolone—ankylosing spondylitis	0.000253	0.000912	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000253	0.000912	CcSEcCtD
Fosphenytoin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000251	0.000906	CcSEcCtD
Fosphenytoin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000251	0.000906	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—ankylosing spondylitis	0.00025	0.000901	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000243	0.000878	CcSEcCtD
Fosphenytoin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000243	0.000876	CcSEcCtD
Fosphenytoin—Dizziness—Betamethasone—ankylosing spondylitis	0.000243	0.000876	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—ankylosing spondylitis	0.000242	0.000872	CcSEcCtD
Fosphenytoin—Nausea—Triamcinolone—ankylosing spondylitis	0.00024	0.000867	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00024	0.000866	CcSEcCtD
Fosphenytoin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00024	0.000865	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000238	0.000859	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—ankylosing spondylitis	0.000237	0.000857	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000235	0.000849	CcSEcCtD
Fosphenytoin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000233	0.000842	CcSEcCtD
Fosphenytoin—Vomiting—Betamethasone—ankylosing spondylitis	0.000233	0.000842	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000232	0.000838	CcSEcCtD
Fosphenytoin—Rash—Dexamethasone—ankylosing spondylitis	0.000231	0.000835	CcSEcCtD
Fosphenytoin—Rash—Betamethasone—ankylosing spondylitis	0.000231	0.000835	CcSEcCtD
Fosphenytoin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000231	0.000834	CcSEcCtD
Fosphenytoin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000231	0.000834	CcSEcCtD
Fosphenytoin—Headache—Dexamethasone—ankylosing spondylitis	0.00023	0.00083	CcSEcCtD
Fosphenytoin—Headache—Betamethasone—ankylosing spondylitis	0.00023	0.00083	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—ankylosing spondylitis	0.000229	0.000828	CcSEcCtD
Fosphenytoin—Pruritus—Prednisone—ankylosing spondylitis	0.000226	0.000816	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00022	0.000794	CcSEcCtD
Fosphenytoin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000219	0.000789	CcSEcCtD
Fosphenytoin—Nausea—Dexamethasone—ankylosing spondylitis	0.000218	0.000787	CcSEcCtD
Fosphenytoin—Nausea—Betamethasone—ankylosing spondylitis	0.000218	0.000787	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—ankylosing spondylitis	0.000212	0.000766	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—ankylosing spondylitis	0.000211	0.000763	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000211	0.000762	CcSEcCtD
Fosphenytoin—Vomiting—Prednisone—ankylosing spondylitis	0.000203	0.000733	CcSEcCtD
Fosphenytoin—Rash—Prednisone—ankylosing spondylitis	0.000202	0.000727	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—ankylosing spondylitis	0.000201	0.000727	CcSEcCtD
Fosphenytoin—Headache—Prednisone—ankylosing spondylitis	0.0002	0.000723	CcSEcCtD
Fosphenytoin—Asthenia—Methotrexate—ankylosing spondylitis	0.000192	0.000692	CcSEcCtD
Fosphenytoin—Nausea—Prednisone—ankylosing spondylitis	0.00019	0.000685	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—ankylosing spondylitis	0.000189	0.000682	CcSEcCtD
Fosphenytoin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000183	0.00066	CcSEcCtD
Fosphenytoin—Dizziness—Methotrexate—ankylosing spondylitis	0.000177	0.000637	CcSEcCtD
Fosphenytoin—Vomiting—Methotrexate—ankylosing spondylitis	0.00017	0.000613	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—ankylosing spondylitis	0.000168	0.000608	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000168	0.000607	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—ankylosing spondylitis	0.000167	0.000604	CcSEcCtD
Fosphenytoin—Nausea—Methotrexate—ankylosing spondylitis	0.000159	0.000573	CcSEcCtD
